ARC's bioequivalence facility offers
bioavailability and bioequivalence studies for
its national and international clients. A
totally new and state-of-the-art center spread
over an area of 12500 sq. ft. was inaugurated in
July 2004. This center has 36 bed facility and
will provide services for pilot bio-studies for
generic formulations.
This facility of ARC is located in the premises
of Bhailal Amin General Hospital, Vadodara,
India. Biostudies with various study designs
such as single blind, double blind, two way
cross over, three way cross over, four way
crossover, parallel design etc. can be conducted
at ARC.
This facility is likely to be operational from
September 2004 onwards. Though a new center is
coming up for this section of service, ARC is
currently working on Bioequivalence projects for
some of its major MNC clients.